Diagnosis for choroideremia in a large Chinese pedigree by next‑generation sequencing (NGS) and non‑invasive prenatal testing (NIPT).

Li Zhu,Jingliang Cheng,Boxu Zhou,Chunli Wei,Weichan Yang,Dong Jiang,Iqra Ijaz,Xiaojun Tan,Rui Chen,Junjiang Fu
DOI: https://doi.org/10.3892/mmr.2017.6119
IF: 3.423
2017-01-01
Molecular Medicine Reports
Abstract:To develop an effective strategy to isolate and use cell -free fetal DNA (cff DNA) for the combined use of next -generation sequencing (NGS) for diagnosing choroideremia and non-invasive prenatal testing (NIPT) for. Y chromosome determination, a large Chinese family with an X -linked recessive disease, choroideremia, was recruited. Cell -free DNA was extracted from maternal plasma, and SRY polymerase chain reaction amplification was performed using NIPT. Sanger sequencing was subsequently used for fetal amniotic fluid DNA verification. A nonsense mutation (c.C799T:p.R267X) of the CHM gene on the X chromosome of the proband (IV:7) and another 5 males with choroideremia were detected, while 3 female carriers with no symptoms were also identified. The fetus (VI:7) was identified as female from the cffDNA, and the same heterozygous nonsense mutation present in her mother was also confirmed. At one and a half years of age, the female baby did circle not present with any associated symptoms of choroideremia. Therefore, cffDNA was successfully used for the combined use of NGS for diagnosing choroideremia in a large Chinese pedigree, and NIPT for Y chromosome determination. This approach should result in a markedly increased use of prenatal diagnosis and improve -
What problem does this paper attempt to address?